Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$0.95
+1.72%
Mkt Cap $255.30M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+5.1%
Consensus $1.00 vs current $0.95
NASDAQ·Healthcare·Biotechnology
$0.95
+1.72%
Mkt Cap $255.30M
Buy
2
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
+5.1%
Consensus $1.00 vs current $0.95